الإحصائيات الأساسية
| CIK | 1342916 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to HNO International, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| September 3, 2025 |
Certified Public Accountants and Advisors A PCAOB Registered Firm 713-489-5635 bartoncpafirm. |
|
| September 3, 2025 |
File No. 024-12607 As filed with the Securities and Exchange Commission on September 3, 2025 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated September 3, 2025 An offering statement pursuant to Regulation A relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”). Information contained in this Prelimina |
|
| August 14, 2025 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 August 14, 2025 HNO International, Inc. |
|
| August 14, 2025 |
Certified Public Accountants and Advisors A PCAOB Registered Firm 713-489-5635 bartoncpafirm. |
|
| August 14, 2025 |
File No. 024-12607 As filed with the Securities and Exchange Commission on August 14 , 2025 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated August 14 , 2025 An offering statement pursuant to Regulation A relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”). Information contained in this Preliminary |
|
| August 14, 2025 |
HNO INTERNATIONAL, INC. FIRST AMENDED 8% CONVERTIBLE PROMISSORY NOTE THIS NOTE, AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE APPLICABLE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS REGISTERED UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS, OR UNLESS AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE MAKER, IS OBTAINED TO THE EFFECT THAT SUCH PLEDGE, SALE, ASSIGNMENT OR TRANSFER IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND SUCH STATE SECURITIES LAWS. |
|
| July 21, 2025 |
SUBSCRIPTION AGREEMENT HNO International, Inc. NOTICE TO INVESTORS The securities of HNO International, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. In |
|
| July 21, 2025 |
File No. 024-12607 As filed with the Securities and Exchange Commission on July 18, 2025 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated July 18, 2025 An offering statement pursuant to Regulation A relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”). Information contained in this Preliminary Offer |
|
| July 21, 2025 |
Certified Public Accountants and Advisors A PCAOB Registered Firm 713-489-5635 bartoncpafirm. |
|
| June 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2024 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-56568 HNO INTERNATIONAL, INC. (Exact name of r |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2025 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATIONAL |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: June 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56568 CUSIP NUMBER 404729 105 (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: April 30, |
|
| April 29, 2025 |
LEGAL SERVICES AGREEMENT This Legal Services Agreement (the “Agreement”) dated as of, and to be effective as of, April 7, 2025 (the “Effective Date”), is by and between Newlan Law Firm, PLLC, by and through its Managing Member, Eric Newlan (“Attorney”), and HNO International Inc. |
|
| April 29, 2025 |
Certified Public Accountants and Advisors A PCAOB Registered Firm 713-489-5635 bartoncpafirm. |
|
| April 29, 2025 |
HNO International, Inc. 50,000,000 Shares of Common Stock OFFERING CIRCULAR HNO International, Inc. 50,000,000 Shares of Common Stock By this Offering Circular, HNO International, Inc., a Nevada corporation, is offering for sale a maximum of 50,000,000 shares of its common stock (the “Offered Shares”), at a fixed price of $0.50-1.00 per share (to be fixed by post-qualification supplement), pursuant to Tier 2 of Regulation A of the United States Securitie |
|
| April 29, 2025 |
SUBSCRIPTION AGREEMENT HNO International, Inc. NOTICE TO INVESTORS The securities of HNO International, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. In |
|
| April 29, 2025 |
HNO INTERNATIONAL, INC. 8% CONVERTIBLE PROMISSORY NOTE THIS NOTE, AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE APPLICABLE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS REGISTERED UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS, OR UNLESS AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE MAKER, IS OBTAINED TO THE EFFECT THAT SUCH PLEDGE, SALE, ASSIGNMENT OR TRANSFER IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND SUCH STATE SECURITIES LAWS. |
|
| April 29, 2025 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 April 29, 2025 HNO International, Inc. |
|
| April 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2025 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATION |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2024 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-56568 HNO INTERNATIONAL, INC. (Exact name of registrant as speci |
|
| March 20, 2025 |
TERMINATION AGREEMENT (RELATING TO THE PATENT PURCHASE AGREEMENT DATED JANUARY 24, 2023) TERMINATION AGREEMENT (RELATING TO THE PATENT PURCHASE AGREEMENT DATED JANUARY 24, 2023) This Termination Agreement ("Agreement"), made and entered into as of March 13, 2025 (“Execution Date”), is by and between Donald Wade Owens residing at 26320 Hayden Lane, Menifee, CA. |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56568 CUSIP NUMBER 404729 105 (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: January 3 |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2025 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission |
|
| January 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56568 CUSIP NUMBER 404729 105 (Check one): ý Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: October 3 |
|
| January 3, 2025 |
SHARE EXCHANGE AGREEMENT This Share Exchange Agreement ("Agreement") is entered into as of January 2, 2025, by and between HNO International, Inc. |
|
| January 3, 2025 |
HNO International Announces an 82% Reduction in Outstanding Shares of Common Stock as 360 Million Shares Have Been Exchanged Houston, TX – January 3, 2025 – HNO International, Inc. |
|
| January 3, 2025 |
CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK The undersigned, Chief Executive Officer of HNO International, Inc. |
|
| January 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2025 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission F |
|
| January 3, 2025 |
SHARE EXCHANGE AGREEMENT This Share Exchange Agreement ("Agreement") is entered into as of January 2, 2025, by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued April 13, 2023 (the “Issuance Date”), in the original principal amount of $20,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued March 8, 2023 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued March 23, 2023 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued December 1, 2021 (the “Issuance Date”), in the original principal amount of $500,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued April 3, 2023 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued September 29, 2022 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued March 1, 2023 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued October 20, 2022 (the “Issuance Date”), in the original principal amount of $50,000, is by and between HNO International, Inc. |
|
| December 20, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2024 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission |
|
| December 20, 2024 |
second Extension TO PROMISSORY NOTE second Extension TO PROMISSORY NOTE This Second Extension (this “Extension”) to the Promissory Note, issued April 17, 2023 (the “Issuance Date”), in the original principal amount of $30,000, is by and between HNO International, Inc. |
|
| November 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2024 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission |
|
| November 12, 2024 |
HNO INTERNATIONAL INC. 41558 Eastman Drive Suite B Murrieta, CA 92562 HNO INTERNATIONAL INC. 41558 Eastman Drive Suite B Murrieta, CA 92562 November 12, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street N.E. Washington, DC 20549 Re: HNO INTERNATIONAL INC. Registration Statement on Form S-1 Filed October 27, 2023 File No. 333-275193 Request for Withdrawal Ladies and Gentlemen: Pursuant to Rule 477 of the Securities Act of 19 |
|
| September 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATIONAL, |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56568 CUSIP NUMBER 404729 105 (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: July 31, |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2024 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATIONAL |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-56568 CUSIP NUMBER 404729 105 (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR For Period Ended: April 30, |
|
| May 8, 2024 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission File |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2024 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATION |
|
| March 5, 2024 | ||
| March 5, 2024 | ||
| March 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2024 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 5, 2024 | ||
| March 5, 2024 | ||
| March 5, 2024 | ||
| March 5, 2024 | ||
| February 21, 2024 |
HNO INTERNATIONAL, INC. 41558 Eastman Drive Suite B Murrieta, California 92562 February 21, 2024 HNO INTERNATIONAL, INC. 41558 Eastman Drive Suite B Murrieta, California 92562 February 21, 2024 VIA EDGAR Division of Corporation Finance Office of Energy & Transportation Securities and Exchange Commission Washington, DC 20549 Attention: Ms. Majmudar Re: HNO International, Inc. Registration Statement on Form S-1 SEC File No. 333-275193 Ladies and Gentlemen: Pursuant to Rule 461 under the Securit |
|
| February 5, 2024 |
As filed with the Securities and Exchange Commission on February 5, 2024 Table of Contents As filed with the Securities and Exchange Commission on February 5, 2024 Registration No. |
|
| January 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2023 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-56568 HNO INTERNATIONAL, INC. (Exact name of registrant as speci |
|
| January 23, 2024 | ||
| January 23, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2024 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission |
|
| January 23, 2024 | ||
| January 23, 2024 | ||
| January 8, 2024 |
14888 Auburn Sky Drive, Draper, UT 84020 (801) 634-1984 brian@businesslegaladvisor. |
|
| January 8, 2024 |
As filed with the Securities and Exchange Commission on January 8, 2024 Table of Contents As filed with the Securities and Exchange Commission on January 8, 2024 Registration No. |
|
| December 19, 2023 | ||
| December 19, 2023 |
As filed with the Securities and Exchange Commission on December 19, 2023 Table of Contents As filed with the Securities and Exchange Commission on December 19, 2023 Registration No. |
|
| December 19, 2023 | ||
| December 19, 2023 |
14888 Auburn Sky Drive, Draper, UT 84020 (801) 634-1984 brian@businesslegaladvisor. |
|
| December 19, 2023 | ||
| December 19, 2023 | ||
| December 19, 2023 | ||
| December 19, 2023 | ||
| December 19, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) HNO INTERNATIONAL, INC. |
|
| December 19, 2023 | ||
| December 19, 2023 | ||
| December 19, 2023 | ||
| December 19, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 |
As filed with the Securities and Exchange Commission on October 27, 2023 Table of Contents As filed with the Securities and Exchange Commission on October 27, 2023 Registration No. |
|
| October 27, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) HNO INTERNATIONAL, INC. |
|
| October 27, 2023 | ||
| October 27, 2023 | ||
| October 27, 2023 |
REGISTRATION RIGHTS AGREEMENT This Registration Rights AGREEMENT (the “Agreement”), dated as of October 9, 2023 (the “Execution Date”), is entered into by and between HNO International, Inc. |
|
| October 27, 2023 |
EQUITY FINANCING AGREEMENT This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of October 9, 2023 (the “Execution Date”), is entered into by and between HNO International, Inc. |
|
| October 27, 2023 | ||
| October 12, 2023 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 9, 2023 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-56568 20-2781289 (State or other jurisdiction of incorporation) (Commission F |
|
| September 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2023 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-56568 HNO INTERNATIONAL, INC. (Exac |
|
| September 14, 2023 | ||
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-SA [X] SEMIANNUAL REPORT PURSUANT TO REGULATION A Or [ ] SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A For the fiscal semiannual period ended April 30, 2023 HNO INTERNATIONAL, INC. (Exact name of issuer as specified in its charter) Nevada 20-2781289 (State or other jurisdiction of incorporation or organization) (I.R |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 HNO INTERNATIONAL, INC. (Name of small business issuer in its charter) Nevada 20-2781289 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 41558 Ea |
|
| May 1, 2023 |
HNO International, Inc. 41558 Eastman Drive Suite B Murrieta, CA 92562 May 1, 2023 Via Edgar United State Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, DC 20549 Attention: Claudia Rios Mitchell Austin Re: HNO International, Inc. Amendment No. 1 to Offering Statement on Form 1-A/A Filed April 14, 2023 File No. 024-12194 Dear Sir or Madam: HNO Int |
|
| April 14, 2023 |
As submitted to the Securities and Exchange Commission on April 14 , 2023 PART II - PRELIMINARY OFFERING CIRCULAR As submitted to the Securities and Exchange Commission on April 14 , 2023 Registration No. |
|
| April 14, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Registration Statement on Form 1-A-A1 of our report dated March 20, 2023, relating to the consolidated financial statements of HNO International, Inc. |
|
| April 14, 2023 |
HNO International, Inc. HNO International, Inc. 41558 Eastman Drive Suite B Murrieta, CA 92562 April 14, 2023 Via Edgar United State Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, DC 20549 Attention: Claudia Rios Mitchell Austin Re: HNO International, Inc. Offering Statement on Form 1-A Filed March 22, 2023 File No. 024-12194 Dear Sir or Madam: H |
|
| April 14, 2023 |
MCMURDO LAW GROUP, LLC Matthew C. McMurdo | 917 318 2865 | [email protected] 1185 Avenue of the Americas 3rd Floor New York, NY 10036 April 14, 2023 HNO INTERNATIONAL, INC. 41558 Eastman Drive Suite B Murrieta, CA 92562 Re: Offering Statement on Form 1-A/A Ladies and Gentlemen: I am counsel for HNO International, Inc., a Nevada corporation (the “Company”), in connection with the proposed publi |
|
| March 22, 2023 | ||
| March 22, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Registration Statement on Form 1-A of our report dated March 22, 2023, relating to the consolidated financial statements of HNO International, Inc. |
|
| March 22, 2023 |
As submitted to the Securities and Exchange Commission on March 22, 2023 PART II - PRELIMINARY OFFERING CIRCULAR As submitted to the Securities and Exchange Commission on March 22, 2023 Registration No. |
|
| March 22, 2023 |
Subscription Agreement HNO INTERNATIONAL, INC. Subscription Agreement HNO INTERNATIONAL, INC. 1. Investment: The undersigned (“Buyer”) subscribes for Shares of Common Stock of HNO International, Inc. (the “Company”) at $1.00 per share. Number of Shares Purchased = Total subscription price ($1.00 x Shares purchased): = $ . PLEASE MAKE CHECK PAYABLE TO: 2. Investor information: Name (type or print) Mailing Address Street City/State Zip SSN/EIN/T |
|
| March 22, 2023 | ||
| March 22, 2023 |
AMENDED AND RESTATED HNO International Inc. (hereinafter called the “Corporation”) ARTICLE I AMENDED AND RESTATED BY-LAWS OF HNO International Inc. (hereinafter called the “Corporation”) ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the corporation shall be established and maintained at the office of NEVADA AGENCY AND TRANSFER COMPANY, at 50 WEST LIBERTY STREET SUITE 880, Reno, NV, 89501, in the State of Nevada; NEVADA AGENCY AND TRANSFER COMPANY shall be the r |
|
| September 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2021 HNO INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commissio |
|
| September 8, 2021 | ||
| August 20, 2019 |
CRGE / Clenergen Corp. 15-15D - - FORM 15-15D OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0167 Expires: May 31, 2021 Estimated average burden hours per response 1.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
| October 31, 2011 |
Dodhurst Farm Cottage Highwoods Lane Tunbridge Wells Kent TN3 9AB 16th October 2011 To the Board of Directors Clenergen Corporation Dear Sir/Madame. I am resigning as a director and Acting Chief Financial Officer of Clenergen Corporation with immediate effect. This is due to personal reasons. Yours Faithfully, F.W.M Starkie |
|
| October 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2011 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission F |
|
| October 20, 2011 |
Certification In connection with the Quarterly Report on Form 10-Q/A of Clenergen Corporation (the “Company”) for the quarter ended July 31, 2011 (the “Form 10-Q”), I, Mike Starkie, the Acting Chief Financial Officer (Principal Financial Officer) of the Company, certify, pursuant to 18 U. |
|
| October 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 3 10-Q/A 1 v23730010qa.htm FORM 10-Q AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 3 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 33 |
|
| October 20, 2011 |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER I, Mark L.M. Quinn, the Executive Chairman of the Board and Chief Executive Officer (Principal Executive Officer) of Clenergen Corporation, certify that: 1. I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of Clenergen Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o |
|
| October 20, 2011 |
Certification In connection with the Quarterly Report on Form 10-Q/A of Clenergen Corporation (the “Company”) for the quarter ended July 31, 2011 (the “Form 10-Q”), I, Mark L. |
|
| October 20, 2011 |
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER I, Mike Starkie, the Acting Chief Financial Officer (Principal Financial Officer) of Clenergen Corporation, certify that: 1. |
|
| October 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2011 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT Commission File Number: 333-130286 Clenergen Corporation (Exact name of registr |
|
| September 21, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2011 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-130286 Clenergen Corporation (Exact name of |
|
| September 20, 2011 |
EX-10.7 2 v235243ex10-7.htm Agreement This agreement is hereby entered into this 17th May 2011 by VASTANI Company SA, Road Town Pasca Estate, Tortola BVI represented by Mr. Jan Malkus, Switzerland herein after referred to as Vastani And Clenergen India, incorporated in India , having its principal executive office at Heavitree Building 47, Spur Tank Road, Chetpet, Chennai, 600031, hereinafter refe |
|
| September 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-130286 Clenergen Corporation (Exact name of registrant as spe |
|
| September 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tr |
|
| September 12, 2011 |
CONFIDENTIAL SHAREHOLDERS AGREEMENT EX-10.4 5 v234589ex10-4.htm EXHIBIT 10.4 CONFIDENTIAL SHAREHOLDERS AGREEMENT This Agreement (this “Agreement”), effective as of 5th September, 2011 (the Effective Date"), summarizes the intentions and mutual understandings of and between FUTENCO AG (“NEWCO”) of and CLENERGEN CORPORATION (CLENERGEN) of 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA. NEWCO and CLENERGEN are hereafte |
|
| September 12, 2011 |
CLENERGEN CORPORATION & FUTENCO AG (“NEWCO”) EX-10.1 2 v234589ex10-1.htm EXHIBIT 10.1 CLENERGEN CORPORATION & FUTENCO AG (“NEWCO”) RE: CLENERGEN FUND TERMS OF AGREEMENT 1. A joint venture between Clenergen Corporation and NEWCO will be formed for the purpose of implementing energy crop plantations in Ghana and Sri Lanka; 2. Clenergen will contribute its plant science resources and supply chains for planting Melia Dubia and Beema Bamboo at pr |
|
| September 12, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): [September 5, 2011] Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of |
|
| September 12, 2011 |
SCHEDULE ONE LICENSE AGREEMENT Licensed Technologies for exclusive use within the territories defined under the License Agreement This Agreement (this ?Agreement?), effective as of September 1, 2011 (the Effective Date"), summarizes the intentions and mutual understandings of and between FUTENCO AG (?NEWCO?) of and CLENERGEN CORPORATION (CLENERGEN) of 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA . |
|
| September 12, 2011 |
EX-10.3 4 v234589ex10-3.htm EXHIBIT 10.3 CONFIDENTIAL SHAREHOLDERS AGREEMENT This Agreement (this “Agreement”), effective as of 5th September 2011 (the Effective Date"), summarizes the intentions and mutual understandings of and between FUTENCO AG (“NEWCO”) of and CLENERGEN CORPORATION (CLENERGEN) of 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA. NEWCO and CLENERGEN are hereafter |
|
| September 12, 2011 |
CONFIDENTIAL TRANSFER AGREEMENT This Agreement (this ?Agreement?), effective as of September 5TH , 2011 (the Effective Date"), summarizes the intentions and mutual understandings of and between MAXRISE POWERGEN LIMITED (MR),of room 2303-7 Dominion Centre, 43-59 Queens Road East, , Hong Kong,, and CLENERGEN CORPORATION (CLENERGEN) of 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA. |
|
| September 12, 2011 |
The Old Rectory The Green Hartest Suffolk IP29 4DH 5th September 2011 Private & confidential Att: Mark Quinn Clenergen Dear Mark Re: Resignation Further to our recent conversations regarding by continuing role as a non executive director, I am hereby tendering my resignation from the board with immediate effect. |
|
| September 12, 2011 |
M.B. SANIL KUMAR Chartered Accountant F-1 Chorus, Kochar Road Sasthamangalam P O Trivandrum ? 695010 Phone: ++ 2725830 Fax: ++ 2722996 E-mail: [email protected] The Board of Directors Clenergen Corporation Consequent to the restructuring of Clenergen Corporation and Clenergen India I believe I may not be able bring in value or facilitate the Company by being in its Board. Hence I would like to resign |
|
| September 12, 2011 |
CONFIDENTIAL SHAREHOLDERS AGREEMENT CONFIDENTIAL SHAREHOLDERS AGREEMENT This Agreement (this ?Agreement?), effective as of 31st August, 2011 (the Effective Date"), summarizes the intentions and mutual understandings of and between FUTENCO AG (?NEWCO?) of and CLENERGEN CORPORATION (CLENERGEN) of 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA . |
|
| September 12, 2011 |
EX-99.5 12 v234589ex99-5.htm EXHIBIT 99.5 FOR IMMEDIATE RELEASE September 8, 2011 Contact: [email protected] www.clenergen.com CLENERGEN CORPORATION CLENERGEN ANNOUNCES A STRATEGIC CHANGE IN ITS BUSINESS MODEL TO BECOME THE WORLDWIDE SUPPLIER OF BIOMASS FEEDSTOCK THROUGH LICENSING AGREEMENTS AND JOINT VENTURES (New York City – September 8, 2011) Clenergen Corporation (OTCQB: CRGE - BOERSE FRA |
|
| September 12, 2011 |
09 September 2011 16 High Road, Bramley, 2090, Johannesburg Resignation For the Attention of Mark Quinn and the Clenergen Board This letter is to inform you that I resign as Non-Executive Director of Clenergen, with immediate effect. |
|
| September 12, 2011 |
Pamela Peeters Productions New York, September 5, 2011 Clenergen Corporation Mark Quinn, Chairman and CEO 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169, USA Dear Mark Contrary to a premature press release announcement, It is my decision to not assume the position as a Director of Clenergen Corporation, as the company was not able to provide Directors and Officer?s Insurance as a requirement for me in order to join the Board. |
|
| June 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-130286 Clenergen Corporation (Exact name of registrant as sp |
|
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: April 30, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o T |
|
| June 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2011 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| June 1, 2011 |
PLEDGE AND ESCROW AGREEMENT THIS PLEDGE AND ESCROW AGREEMENT (“Agreement”) is made and entered into as of this 21st day of May, 2011, by and between CLENERGEN CORPORATION, a Nevada corporation (the “Company” or “Pledgor”) and TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Secured Party”), with the joinder of DAVID KAHAN, P. |
|
| June 1, 2011 |
EX-10.1 2 v224513ex10-1.htm PROMISSORY NOTE $300,000.00 May 21, 2011 FOR VALUE RECEIVED, CLENERGEN CORPORATION, a Nevada corporation (hereinafter referred to as the “Borrower”) promises to pay to the order of TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership, with a mailing address of 1404 Rodman Street, Hollywood, Florida 33020 (together with its successors and/or assigns, h |
|
| May 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2011 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 25, 2011 |
FOR IMMEDIATE RELEASE May 24, 2011 FOR IMMEDIATE RELEASE May 24, 2011 Contact: [email protected] www.clenergen.com CLENERGEN CORPORATION CLENERGEN RESTRUCTURES ITS BOARD OF DIRECTORS IN PREPARATION FOR INSTITUTIONAL FUND RAISING IN NORTH AMERICA. Clenergen announced today that it has restructured its Board of Directors in preparation for its expected institutional fundraising efforts in North America. Alex Worrall has been app |
|
| March 28, 2011 |
Clenergen Corporation Bath House 8 Chapel Place London, Great Britain EC2A 3DQ +44 (0) 207739 0028 Clenergen Corporation Bath House 8 Chapel Place London, Great Britain EC2A 3DQ +44 (0) 207739 0028 March 28, 2011 VIA FAX AND EDGAR SUBMISSION Cecilia Blye, Chief Office of Global Security Risk United States Securities and Exchange Commission Washington, D. |
|
| March 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-131862 Clenergen Corporation (Exact name of registrant as |
|
| March 22, 2011 |
PROMISSORY NOTE Feb 16, 2010 Borrower: Clenergen Corporation, a Nevada corporation with principal offices at Bath House, Chapel Place, London, Great Britain EC2A 3DQ. |
|
| March 22, 2011 |
AMENDED EXCLUSIVE license agreement Between CLENERGEN CORPORATION And BIOPOWER CORPORATION 1 March 9, 2011 AMENDED EXCLUSIVE LICENSE AGREEMENT This Agreement (the "Agreement"), dated March 9, 2011 supersedes the original agreement dated November 30, 2010 (the Effective Date) and is entered into by and between Clenergen Corporation, a Nevada corporation and public company (Licensor) and BioPower Corporation, a Florida corporation (Licensee). |
|
| March 18, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o |
|
| March 17, 2011 |
9th March 2010 Ms Cecilia Blye Chief, Office of Global Security Risk United States, SEC Washington, D. |
|
| February 14, 2011 |
TECHNO-COMMERCIAL AGREEMENT This AGREEMENT, executed at Romblon State University, Philippines, on this 5th day of December, 2010, between: CLENERGEN PHILIPPINES CORPORATION, a Philippine corporation organized under Philippine laws with office address at Unit 311, The Annex, No. |
|
| February 14, 2011 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 26th day of March 2010. |
|
| February 14, 2011 |
EXCLUSIVE license agreement CLENERGEN CORPORATION BIOPOWER CORPORATION November 30, 2010 EX-10.23 12 v211066ex10-23.htm EXCLUSIVE license agreement Between CLENERGEN CORPORATION And BIOPOWER CORPORATION November 30, 2010 1 LICENSE AGREEMENT This Agreement (the "Agreement"), dated November 30, 2010 (the Effective Date) is entered into by and between Clenergen Corporation, a Nevada corporation and public company (Licensor) and BioPower Corporation, a Florida corporation (Licensee). WHER |
|
| February 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2010 Commission file number: 333-130286 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 20-2781289 (State or other jurisdiction of (I.R.S. Employer incorporati |
|
| February 14, 2011 |
Certification In connection with the Annual Report on Form 10-K of Clenergen Corporation (the “Company”) for the year ended October 31, 2010 (the “Form 10-K”), I, Mark L. |
|
| February 14, 2011 |
SHARE PURCHASE AGREEMENT BETWEEN Clenergen India And Enkem Engineers Private Limited i SHARE PURCHASE AGREEMENT THIS AGREEMENT is executed on this 12th day of December 2009 by and between: 1. |
|
| February 14, 2011 |
Certification In connection with the Annual Report on Form 10-K of Clenergen Corporation (the “Company”) for the year ended October 31, 2010 (the “Form 10-K”), I, Mike Starkie, the acting chief financial and accounting officer of the Company, certify, pursuant to 18 U. |
|
| February 14, 2011 |
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER I, Mike Starkie, the acting chief financial and accounting officer of Clenergen Corporation, certify that: 1. |
|
| February 14, 2011 |
ASSET PURCHASE AGREEMENT THIS AGREEMENT dated for reference the 24th day of April, 2010. |
|
| February 14, 2011 |
TECHNO-COMMERCIAL AGREEMENT BETWEEN CLENERGEN CORPORATION AND BIOMASS 2 BIOPOWER (QA) LIMITED AND ENHANCED BIOFUELS AND TECHNOLOGIES PRIVATE LIMITED JUNE 2ND 2010 TECHNO-COMMERCIAL AGREEMENT Dated June 2nd 2010This Agreement by Biomass2Biopower (QA) Limited, a Company incorporated in Tamilnadu, with registered address at, 5/10 C Alankar Garden, GN Mills post, Coimbatore 641 029 India and Enhanced |
|
| February 14, 2011 |
MEMORANDUM OF AGREEMENT This AGREEMENT, executed at Kalinga, Philippines, on this 9th day of December, 2010, between: CLENERGEN PHILIPPINES CORPORATION, a Philippine corporation organized under Philippine laws with office address at Unit 311, The Annex, No. |
|
| February 14, 2011 |
MEMORANDUM OF AGREEMENT Dated May 17th 2010 MEMORANDUM OF AGREEMENT Dated May 17th 2010 This Agreement by Growmore Biotech Limited, a Company incorporated in Tamilnadu, with registered address at 43, Main road, Sri Ramiah Building, Kovilpatti- 628501, Tamilnadu, India (hereinafter referred to as GBL) AND Clenergen Corporation, a Company registered in the State of Nevada, USA and registered address at Bath House, 8 Chapel Place, London EC2A 3DQ (hereinafter referred to as CC). |
|
| February 14, 2011 |
CLENERGEN CORPORATION Terms of reference of the Audit Committee approved by the Board on 11 May 2010 In these terms of reference: The “Committee” means the Audit Committee The ‘Board’ means the board of directors of the Company. |
|
| February 14, 2011 |
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER I, Mark L.M. Quinn, the chief executive officer of Clenergen Corporation, certify that: 1. I have reviewed this Annual Report on Form 10-K of Clenergen Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circums |
|
| February 14, 2011 |
EX-10.25 14 v211066ex10-25.htm Bowen FM Clenergen Corporation 5379 Lyons Road, Suite 301 Coconut Creek, Florida 33073 USA January 24, 2011 Dear Mark Consultancy Agreement Further to our recent discussions, I write to confirm the terms and conditions upon which Bowen Financial Management Limited ("the Consultant") agrees provide continuing consultancy services to Clenergen Corporation ("the Company |
|
| February 14, 2011 |
MEMORANDUM OF AGREEMENT Is entered into between CLENERGEN PHILIPPINES CORPORATION, a Philippine corporation organized under Philippine laws with office address at Unit 311, The Annex, No. |
|
| February 14, 2011 |
POWER PURCHASE AGREEMENT THIS POWER PURCHASE AGREEMENT (the ?Agreement?) is entered into this 5th day of December 2010 between: Romblon State University, a Philippine State University with principal office address at Odiongan, Romblon herein represented by its President, DR. |
|
| February 14, 2011 |
?Clenergen Corporation CODE OF ETHICS (Senior Executive Officers) At Clenergen Corporation (the ?Company?), we are committed to conducting our business in an honest, lawful and ethical manner. |
|
| February 1, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: October 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| January 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2011 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission F |
|
| November 3, 2010 |
FOR IMMEDIATE RELEASE November 3, 2010 FOR IMMEDIATE RELEASE November 3, 2010 Contact: Jessica Hatfield Tel: 0044 (0)207 739 0028 Fax: 0044 (0)207 657 3275 www. |
|
| November 3, 2010 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission F |
|
| November 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of in |
|
| October 27, 2010 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of in |
|
| October 27, 2010 |
EX-99.1 2 v200083ex99-1.htm NEWS RELEASE TRANSMITTED BY MARKETWIRE FOR: CLENERGEN CORPORATION OTCQB SYMBOL: CRGE FRANKFURT SYMBOL: 9CE October 27, 2010 Clenergen Corporation Signs Dual Listing on the Frankfurt Stock Exchange "Open Market" With Immediate Effect FRANKFURT, GERMANY—(Marketwire - Oct. 27, 2010) - Clenergen Corporation (OTCQB:CRGE)(FRANKFURT:9CE) today announced the initial listing of |
|
| September 21, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 17th day of April, 2010. |
|
| September 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2010 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-130286 Clenergen Corporation (Exact name of registrant as spe |
|
| September 21, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 17th day of April, 2010. |
|
| September 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: July 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tr |
|
| September 7, 2010 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of i |
|
| September 7, 2010 |
Sehr geehrter Aktionär, Der Aufsichtsrat von Clenergen sowie das komplette Management-Team begrüßen Sie ganz herzlich als neuen Aktionär in unserer Gesellschaft. |
|
| August 11, 2010 |
EX-10.2 3 v193247ex10-2.htm NEITHER THIS NOTE NOR THE SHARES OF COMMON STOCK OR ANY OTHER SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE HAS BEEN ACQUIRED, AND ANY SHARES OF COMMON STOCK OR ANY OTHER SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE ARE REQUIRED TO BE ACQUIRED, FOR INVESTMENT PURPOSES AND NOT WITH A VIEW |
|
| August 11, 2010 |
Clenergen Corporation 1% Promissory Note Dated: August 5, 2010 Principal Amount: $303,730.50 EX-10.1 2 v193247ex10-1.htm Clenergen Corporation 1% Promissory Note Dated: August 5, 2010 Principal Amount: $303,730.50 Coconut Creek, Florida 33073 For Value Received, the undersigned, Clenergen Corporation, a Nevada corporation (“Maker”), hereby promises to pay to Rootchange Limited, a corporation organized under the laws of Great Britain (“Payee”), the principal sum of $303,730.50 together wit |
|
| August 11, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of inco |
|
| August 4, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission File |
|
| July 30, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2010 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-131862 Clenergen Corporation (Exact name |
|
| June 24, 2010 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| June 24, 2010 |
PRESS RELEASE FOR IMMEDIATE RELEASE June 21, 2010 Contact: Jessica Hatfield Tel: 0044 (0)207 739 0028 Fax: 0044 (0)207 657 3275 www. |
|
| June 24, 2010 |
June 18, 2010 THE SELLING SHAREHOLDERS NAMED IN SCHEDULE I NANDHA ENERGY LIMITED CLENERGEN INDIA PRIVATE LIMITED AGREEMENT TO SELL AND PURCHASE SHARES TABLE OF CONTENTS 1. |
|
| June 21, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2010 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-131862 Clenergen Corporation (Exact name of registrant as sp |
|
| June 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: April 30, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o T |
|
| June 8, 2010 |
v187605ex10-1 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| June 8, 2010 |
PRESS RELEASE FOR IMMEDIATE RELEASE 8th June 2010 Contact: Jessica Hatfield Communications Director Clenergen Corporation Tel: 00 44 (0) 207 739 0028 Fax: 00 44 (0) 207 657 3275 www. |
|
| June 8, 2010 |
v187605ex10-2 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| June 8, 2010 |
Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| June 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission File |
|
| May 18, 2010 |
EX-10.2 3 v185801ex10-2.htm PROMISSORY NOTE $250,000.00 May 14, 2010 For value received, Clenergen Corporation, a Nevada corporation with principal offices at Bath House, Chapel Place, London, Great Britain EC2A 3DQ ("Borrower"), promises to pay to the order of Vastani Trading Limited, a British Virgin Islands corporation with principal offices at Friededstrasstrabe 6-O, Frankfurt 60311 Germany (t |
|
| May 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incorp |
|
| May 18, 2010 |
Securities Purchase Agreement This Securities Purchase Agreement, dated as of May 14, 2010 (this “Agreement”), is by and between Clenergen Corporation, a Nevada corporation (the “Company”), and Vastani Trading Limited, a British Virgin Islands corporation (“Investor”). |
|
| May 18, 2010 |
NEITHER THE WARRANTS REPRESENTED BY THIS WARRANT CERTIFICATE NOR THE SHARES OF COMMON STOCK NOR HAVE ANY OTHER SECURITIES ISSUABLE UPON EXERCISE OF SUCH WARRANTS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. |
|
| April 12, 2010 |
EX-10.15 11 v180601ex10-15.htm ROOTCHANGE LIMITED and CLENERGEN CORPORATION LIMITED Dated: April 1st 2009. PURCHASE AND SALES SALE AGREEMENT AGREEMENT: BETWEEN: ROOTCHANGE LIMITED (previously named MGS Development Company Limited) a company registered in England and Wales whose registered office is situate at 14 Chester Street, London SW1X 7BB, UK (the Seller) and CLENERGEN CORPORATION LIMITED a c |
|
| April 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of incor |
|
| April 12, 2010 |
Composite of the Articles of Incorporation Clenergen Corporation (As amended through March 19, 2009) Composite of the Articles of Incorporation of Clenergen Corporation (As amended through March 19, 2009) I. |
|
| April 12, 2010 | ||
| April 12, 2010 |
v177242ex10-18 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| April 12, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 1st of January, 2010. |
|
| April 12, 2010 | ||
| April 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2009 Commission file number: 333-130286 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 20-2781289 (State or other jurisdiction of (I.R.S. Em |
|
| April 12, 2010 |
v177242ex10-17 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| April 12, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 29th day of August, 2009. |
|
| April 12, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 29th day of August, 2009. |
|
| April 12, 2010 |
Subsidiaries Clenergen Corporation Subsidiaries of Clenergen Corporation State or Jurisdiction of Name of Entity Organization Clenergen India Private Limited Tamilnadu, India Clenergen Biopower Corporation Florida Clenergen Corporation Limited (UK) England and Wales |
|
| April 12, 2010 | ||
| March 31, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of inco |
|
| March 31, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 26th day of March 2010. |
|
| March 24, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2010 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-131862 Clenergen Corporation (Exact name |
|
| March 24, 2010 |
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER I, Mike Starkie, the acting chief financial and accounting officer of Clenergen Corporation, certify that: 1. |
|
| March 24, 2010 |
Certification In connection with Amendment No. 1 of the Quarterly Report on Form 10-Q/A of Clenergen Corporation (the “Company”) for the quarter ended January 31, 2010 (the “Amended Form 10-Q”), I, Mike Starkie, the acting chief financial and accounting officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that: (a) The Amended F |
|
| March 24, 2010 |
Certification In connection with Amendment No. 1 of the Quarterly Report on Form 10-Q/A of Clenergen Corporation (the “Company”) for the quarter ended January 31, 2010 (the “Amended Form 10-Q”), I, Mark L.M. Quinn, the chief executive officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that: (a) The Amended Form 10-Q fully comp |
|
| March 24, 2010 |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER I, Mark L.M. Quinn, the chief executive officer of Clenergen Corporation, certify that: 1. I have reviewed this Amendment No. 1 of the Quarterly Report on Form 10-Q/A of Clenergen Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m |
|
| March 23, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2010 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-131862 Clenergen Corporation (Exact name of registrant as |
|
| March 22, 2010 |
v177242ex10-18 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| March 22, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 29th day of August, 2009. |
|
| March 22, 2010 | ||
| March 22, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 29th day of August, 2009. |
|
| March 22, 2010 |
Composite of the Articles of Incorporation Clenergen Corporation (As amended through March 19, 2009) Composite of the Articles of Incorporation of Clenergen Corporation (As amended through March 19, 2009) I. |
|
| March 22, 2010 |
Subsidiaries Clenergen Corporation EX-22.1 60 v177242ex22-1.htm Subsidiaries of Clenergen Corporation State or Jurisdiction of Name of Entity Organization Clenergen India Private Limited Tamilnadu, India Clenergen Biopower Corporation Florida Clenergen Corporation Limited (UK) England and Wales |
|
| March 22, 2010 |
ROOTCHANGE LIMITED and CLENERGEN CORPORATION LIMITED Dated: April 1st 2009. PURCHASE AND SALES SALE AGREEMENT AGREEMENT: BETWEEN: ROOTCHANGE LIMITED (previously named MGS Development Company Limited) a company registered in England and Wales whose registered office is situate at 14 Chester Street, London SW1X 7BB, UK (the Seller) and CLENERGEN CORPORATION LIMITED a company registered in England an |
|
| March 22, 2010 |
v177242ex10-17 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing |
|
| March 22, 2010 |
10-K 1 v17724210k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2009 Commission file number: 333-130286 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 20-2781289 (State or other jurisdiction of (I.R.S |
|
| March 22, 2010 |
CONSULTING AGREEMENT THIS AGREEMENT is dated for reference the 1st of January, 2010. |
|
| March 22, 2010 | ||
| March 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing SEC File Number: 333-130286 CUSIP Number: 185635 10 9 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: January 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o |
|
| February 17, 2010 |
Jessica Hatfield February 2010 PRESS RELEASE FOR IMMEDIATE RELEASE Contact: Jessica Hatfield February 2010 Communications Director Clenergen Corporation Tel: 0044 (0)207 739 0028 Fax: 0044 (0)207 657 3275 www. |
|
| February 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2010 Clenergen Corporation (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction (Commission (IRS Employer of in |
|
| November 23, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2009 CLENERGEN CORPORATION (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 23, 2009 |
Letter from Chang G. Park, CPA Filed by sedaredgar.com - Clenergen Corporation - Exhibit 16.1 |
|
| November 10, 2009 | ||
| November 10, 2009 |
EX-10.8 8 exhibit10-8.htm STRATEGIC MARKETING AGREEMENT DATED JUNE 2009 STRATEGIC MARKETING AGREEMENT THIS AGREEMENT made as of June, 2009 by and between Clenergen Corporation Limited (UK) Bath House, 8 Chapel Place, London EC2A 3DQ, (the "Company"), and Villasam Company Limited . (the "Representative"), a Ghana corporation with a business address at Ghana International Trade Fair Centre, 20th Cen |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.6 DATED: SEPTEMBER 11, 2009 (1) CLENERGEN CORPORATION (2) EUROGET DE-INVEST STRATEGIC ALLIANCE AGREEMENT THIS AGREEMENT is made on September 11, 2009 by and between CLENERGEN CORPORATION a US public company incorporated in Nevada (CLENERGEN) with principal offices at 5379 Lyons Road, Suite 301, Coconut Creek, FL 33073 USA, and EUROGET DE |
|
| November 10, 2009 |
Memorandum of Agreement between Clenergen India Private Limited and Sree Emberumanar Jeer Mutt EX-10.16 16 exhibit10-16.htm MEMORANDUM OF AGREEMENT |
|
| November 10, 2009 |
National Power Corporation Request to Submit Proposal Dated October 28, 2009. Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.11 October 28, 2009 Mr. Mark LM Quinn Chief Executive Officer Clenergen Corporation Bath House 8 Chapel Place London ECZA. 3DO, UK Dear Mr. Quinn, Following our Manila meeting September 29, 2009, we would like to request Clenergen Corporation to submit an unsolicited proposal for biomass based power plants ranging from 1 – 2 – 4 – 8 MWs |
|
| November 10, 2009 |
Letter from Maurai Kamaraj University dated September 17, 2009 Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.17 |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2009 CLENERGEN CORPORATION (Exact name of registrant as specified in its charter) Nevada 333-130286 20-2781289 (S |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.5 |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Exhibit 99.2 Unaudited Proforma Condensed Combined Balance Sheets July 31, 2009 Historical Clenergen Proforma Clenergen UK Corporation Adjustments Proforma ASSETS Current Assets Cash $ 25,675 $ 363 $ - $ 26,038 Receivables - Related Parties 53,761 - - 53,761 Total Current Assets 79,435 363 - 79,798 Property & Equipment - Net 6,670 - - 6,670 Other A |
|
| November 10, 2009 |
EX-10.2 2 exhibit10-2.htm COMMERCIAL LEASE AGREEMENT DATED SEPTEMBER 11, 2009 COMMERCIAL LEASE AGREEMENT THIS LEASE AGREEMENT is made and entered into this the Eleventh Day of September 2009, by and between Archana Spinners Limited, whose address is 27/6, Second Street, Muniaswamipuram, Tuticorin- 628003, Tamilnadu, represented by Mr M S Rajaraman, Managing Director (hereinafter referred to as "La |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.13 |
|
| November 10, 2009 |
Letter from the Russian Society of Biotechnologists Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.15 |
|
| November 10, 2009 |
Contract dated June 30, 2009 between Clenergen Limited and Applied Heat Engineering Limited Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.3 CONTRACT REFERENCE CI 760 DATED 30 JUNE 2009 BETWEEN CLENERGEN LIMITED AND APPLIED HEAT ENGINEERING LIMITED AGREEMENT OF CONTRACT THIS AGREEMENT is made on the 30TH day of JUNE 2009. BY AND BETWEEN: (1) CLENERGEN LIMITED, registered in USA, company number …………… whose registered office is at ……………………………………………………………. …………………………………………………… |
|
| November 10, 2009 |
License Agreement dated October 2009 between Clenergen Corporation and Star Biotechnology Limited. Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.12 |
|
| November 10, 2009 |
DATE JUNE 2009 (1) CLENERGEN CORPORATION LIMITED AND VILLASAM COMPANY LIMITED BIOMASS SUPPLY AGREEMENT AGREEMENT is made on BETWEEN:- (1) CLENERGEN CORPORATION LIMITED a Company registered in England and Wales ("CUSTOMER "); (2) VILLASAM COMPANY LIMITED a Company registered in Ghana ("SUPPLIER"); All Biomass and Services are supplied subject to Customer?s standard terms end conditions detailed below (this ?Agreement?). |
|
| November 10, 2009 |
REPORT ON AUDITS OF CONSOLIDATED FINANCIAL STATEMENTS CLENERGEN CORPORATION LIMITED AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) REPORT ON AUDITS OF CONSOLIDATED FINANCIAL STATEMENTS Years Ended October 31, 2008 and 2007, Period from( inception) October 27, 2005 to October 31, 2008 and Nine Months Ended July 31, 2009 and 2008 (Unaudited) CLENERGEN CORPORATION LIMITEDAND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) Contents Pages Consolidated Financial St |
|
| November 10, 2009 |
EX-10.14 14 exhibit10-14.htm MEMORANDUM OF AGREEMENT DATED OCTOBER 6, 2009 |
|
| November 10, 2009 |
Filed by sedaredgar.com - Clenergen Corporation - Exhibit 10.18 DATE APRIL 1ST 2009 (1) CLENERGEN INDIA PRIVATE LIMITED AND (2) IJM CONSTRUCTIONS BIOMASS SUPPLY AGREEMENT AGREEMENT is made on April 1st 2009 BETWEEN:- (1) CLENERGEN INDIA PRIVATE LIMITED a Company registered in Tamilnadu, India ("CUSTOMER "); (2) IJM CONSTRUCTIONS a Company registered in Tamilnadu India ("SUPPLIER"); All Biomass and |
